Nephro Care India Limited — PPTs, 12-08-2025: Investor Presentation

**Financial Highlights:**

Nephro Care India saw strong FY25 revenue at ₹46.03 Cr, up from ₹27.23 Cr in FY24. EBITDA also improved to ₹7.40 Cr from ₹6.84 Cr, signaling robust operational performance.

**Strategic Initiatives & Growth Drivers:**

Key growth drivers include expanding Vivacity hospital from 150 to 250 beds. Kidney transplant operations will commence in Q3 FY26, targeting 25 transplants this fiscal, a major profit and revenue boost.

**Business Developments:**

Company is exploring profit-sharing partnerships with local nephrology clinics nationwide. Its flagship Vivacity Hospital, with 150 beds and AI-powered OTs, achieved 40% occupancy and treated 3,400+ patients in FY25.

**Market Position & Competitive Advantage:**

A leader in Eastern India's kidney care, Nephro Care offers an integrated hub-and-spoke model. Advanced AI facilities and deep founder expertise in a high-demand, underserved market (US$11.3B dialysis by 2033) bolster its competitive edge.

**Investor Implications:**

With solid financials and strategic expansion into high-margin services, Nephro Care exhibits positive growth potential. Investors should closely watch execution of hospital capacity and transplant targets.